Effectiveness of Moderate Acute Normovolemic Hemodilution Combined with Tranexamic Acid on the Reduction of Allogenic Blood Transfusion in Patients Undergoing Off-pump Coronary Artery Bypass

Document Type : Original Article


1 Anesthesiologist, Department of Anesthesiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

2 Cardiac Surgeon, Department of Cardiac Surgery, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran


Introduction: There are different approaches to reduce the amount of blood loss and allogenic transfusion in cardiac surgery. Regarding this, the present study aimed to evaluate the blood sparing effect of acute normovolemic hemidilution (ANH) combined with intrao-perative tranexamic acid in patients undergoing off-pump coronary artery bypass (OPCAB).
Material and Methods: This study was conducted on 80 consecutive patients scheduled for elective OPCAB. The patients were randomly subjected to tranexamic acid treatment (TA group) or to tranexamic acid plus ANH (ANH group). All data, including demographic information, allogenic transfusions (based on a prior defined criteria), amount of postoperative bleeding, and major complications, were recorded.
Results: According to the results, the two groups were comparable in terms of the demographic data and intraoperative variables. The mean values of postoperative bleeding were 483±125 and 580±201 mL in the TA and ANH groups, respectively, indicating no significant difference between them in this regard. Total transfused packed red blood cells (PRBC) used in the TA and ANH groups were 15 and 20 units, respectively, which revealed no significant difference between the two groups in this respect (P=0.23). Furthermore, 12 and 10 patients in the TA and ANH groups were transfused with PRBC, respectively. Moreover, the two groups showed no significant difference in terms of the postoperative hematological variables (P>0.05).
Conclusion: As the findings of the present study indicated, ANH was not effective in reducing postoperative bleeding and the need for allogenic blood products in the patients undergoing OPCAB.


1.Adler Ma SC, Brindle W, Burton G, Gallacher S, Hong FC, Manelius I, et al. Tranexamic acid is associated with less blood transfusion in off-pump coronary artery bypass graft surgery: A systematic review and meta-analysis. J Cardiothorac Vasc Anesth.2011; 25:26-35.
2. Taghaddomi RJ, Mirzaee A, Attar AS, Shirdel A. Tranexamic acid reduces blood loss in off-pump coronary artery bypass surgery. J Cardiothorac Vasc Anesth. 2009; 23:312-5.
3. Barrons RW, Jahr JS. A review of post-cardiopulmonary bypass bleeding, aminocaproic acid, tranexamic acid, and aprotinin. Am J Ther. 1996; 3:821-38.
4. Laupacis A, Fergusson D. Drugs to minimize perioperative blood loss in cardiac surgery: Meta-analyses using perioperative blood transfusion as the outcome. The international study of perioperative transfusion (ISPOT) investigators. Anaesth Analg. 1997; 85:1258-67.
5. Wong Bl, McLean RF, Fremes SE, Deemar KA, Harrington EM, Christakis GT, et al. Aprotinin and tranexamic acid for high transfusion risk cardiac surgery. Ann Thorac Surg. 2000; 69:808-16.
6. Andreasen JJ, Nielsen C. Prophylactic tranexamic acid in elective, primary coronary bypass surgery using cardiopulmonary bypass. Eur J Cardiothorac Surg. 2004; 26:311-7.
7. Casati V, Gerli C, Franco A, Torri G, D'Angelo A, Benussi S, et al. Tranexamic acid in off-pump coronary surgery: a preliminary, randomized, double-blind placebo-controlled study. Ann Thorac Surg. 2001; 72:470-5.
8. Casati V, Della Valle PD, Benussi S, Franco A, Gerli C, Baili P, et al. Effects of tranexamic acid on postoperative bleeding and related hematochemical variables in coronary surgery: comparison between on-pump and off-pump techniques. J Thorac Cardiovasc Surg. 2004; 128:83-91.
9. Jares M, Vanek T, Straka Z, Brucek P. Tranexamic acid reduces bleeding after off-pump coronary artery bypass grafting. J Cardiovasc Surg. 2003; 44:205-8.
10. Vanek T, Jares M, Fajt R, Straka Z, Jirasek K, Kolesar M, et al. Fibrinolytic inhibitors in off-pump coronary surgery: A prospective, randomized, double-blind TAP study (tranexamic acid, aprotinin, placebo). Eur J Cardiothorac Surg. 2005; 28:563-8.
11. Murphy GJ, Mango E, Lucchetti V, Battaglia F, Catapano D, Rogers CA, et al. A randomized trial of tranexamic acid in combination with cell salvage plus a meta-analysis of randomized trials evaluating tranexamic acid in off-pump coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2006; 132:475-80.
12. Mehr-Aein A, Sadeghi M, Madani-civi M. Does tranexamic acid reduce blood loss in off-pump coronary artery bypass? Asian Cardiovasc Thorac Ann. 2007; 15:285-9.
13. Wei M, Jian K, Guo Z, Wang L, Jiang D, Zhang L, et al. Tranexamic acid reduces postoperative bleeding in off-pump coronary artery bypass grafting. Scand Cardiovasc J. 2006; 40:105-9.
14. Sedrakyan A, Treasure T, Elefteriades JA. Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials. J Thorac Cardiovasc Surg. 2004; 128:442-8.
15. Englberger L, Markart P, Eckstein FS, Immer FF, Berdat PA, Carrel TP. Aprotinin reduces blood loss in off-pump coronary artery bypass (OPCAB) surgery. Eur J Cardiothorac Surg. 2002; 22:545-51.
16. Virmani S, Tempe DK, Pandey BC, Cheema AS, Datt V, Garg M, et al. Acute normovolemic hemodilution is not beneficial in patients undergoing primary elective valve surgery. Ann Card Anaesth. 2010; 13:34-8.
17. Practice Guidelines for blood component therapy: a report by the American society of anaesthe-siologists task force on blood component therapy. Anaesthesiology. 1996; 84:732-47.
18. Bryson GL, Laupacis A, Wells GA. Does acute normovolemic hemodilution reduce perioperative allogenic transfusion? A meta-analysis. Anesth Analg. 1998; 86:9-15.
19. Segal JB, Blasco-Colmenares E, Norris EJ, Guallar E. Perioperative acute normovolemic hemodilution: a meta-analysis. Transfusion. 2004; 44:632-44.
20. Casati V, Benussi S, Sandrelli L, Graddo MA, Spagnolo S, D` Angelo A. Intraoperative Moderate Acute Normovolemic Hemodilution associated with a comprehensive blood-sparing protocol in off-pump coronary surgery. Anesth Analg. 2004; 98:1217-23.
21. Wang G, Xie G, Jiang T, Wang Y, Wang W, Ji H, et al. Tranexamic acid reduces blood loss after off-pump coronary surgery: A prospective, randomized, double-blind, placebo-controlled study. Anesth Analg. 2012; 115:239-43.
22. Myles PS, Smith JA, Forbes A, Silbert B, Jayarjah M, Painter T, et al. Tranexamic acid in patients undergoing coronary-artery surgery. N Engl J Med. 2017; 376:136-48.
23. Sigaut S, Tremey B, Outtara A, Couturier R, Taberlet C, Grassin- Delyle S, et al. Comparison of two doses of tranexamic acid in adults undergoing cardiac surgery with cardiopulmonary bypass. J Am Soc Anesthesiol. 2014; 120:590-600.